According to Haemonetics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.79042. At the end of 2023 the company had a P/S ratio of 3.42.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.42 | -3.09% |
2022 | 3.52 | 23.95% |
2021 | 2.84 | -58.31% |
2020 | 6.82 | 17.74% |
2019 | 5.79 | 8.1% |
2018 | 5.36 | 56.98% |
2017 | 3.41 | 48.04% |
2016 | 2.31 | 25.75% |
2015 | 1.83 | -11.96% |
2014 | 2.08 | -9.73% |
2013 | 2.31 | -9.32% |
2012 | 2.54 | 18.34% |
2011 | 2.15 | -7.06% |
2010 | 2.31 | 4.99% |
2009 | 2.20 | -10.4% |
2008 | 2.46 | -24.66% |
2007 | 3.26 | 21.62% |
2006 | 2.68 | -15.47% |
2005 | 3.18 | 29.18% |
2004 | 2.46 | 43.56% |
2003 | 1.71 | 10.31% |
2002 | 1.55 | -44.95% |
2001 | 2.82 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 4.14 | 9.26% | ๐บ๐ธ USA |
Medtronic MDT | 3.52 | -7.18% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | 5.32 | 40.32% | ๐บ๐ธ USA |
Baxter BAX | 1.20 | -68.25% | ๐บ๐ธ USA |
Becton Dickinson BDX | 3.51 | -7.44% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.07 | 60.12% | ๐บ๐ธ USA |
PerkinElmer
PKI | 4.31 | 13.59% | ๐บ๐ธ USA |
Cerus CERS | 2.32 | -38.86% | ๐บ๐ธ USA |